All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Jul 24, 2017
Awareness of Opioid Dangers May Be Reducing Prescribing, CDC Finds
Jul 20, 2017
DEA Cites Medicare Exclusion as Basis for Denial of Application
Jul 18, 2017
Pharmacists, Doctors Caught in ‘Strike Force’ Web Targeting Health Care Fraud
Jul 17, 2017
DEA Proposes to Decontrol Recently Approved Naldemedine
Jul 14, 2017
Manufacturer Must Monitor Downstream Purchases of Opioids, Under Settlement Agreement
Jul 10, 2017
Bail Condition Set in Criminal Case Not Basis for Registration Revocation
Jun 28, 2017
Conviction for Medicaid Fraud Leads to Revocation of Medical License, Loss of DEA Registration
Jun 26, 2017
Oklahoma Physician Charged With Five Counts of Second-degree Murder
Jun 19, 2017
‘Impairment’ Results in Loss of Three DEA Registrations
Jun 12, 2017
OIG to Review DEA Enforcement Efforts as Senate Committee Seeks Detailed Data
Jun 6, 2017
Office Manager Indicted for Fraud, Oxycodone Distribution
Jun 5, 2017
Another Fentanyl Analogue in Queue for Emergency Scheduling
May 26, 2017
Wyoming Practitioner’s Medical License Suspended, DEA Registration Revoked
May 22, 2017
Physician Loses Registration After Material Falsification, Loss of License
May 15, 2017
Federal Appeals Court Upholds 20-year Sentence for ‘Pill Mill’ Doctor
May 10, 2017
National Take Back Day Gains Traction; Next Event Oct. 28
May 4, 2017
Another Fentanyl Synthetic Opioid Designer Drug Moved to Temporary Schedule I Control
May 1, 2017
Practitioner Cited for Lack of State Authority, Illegal Transportation
Apr 28, 2017
Application Denied for West Virginia Physician Who Surrendered State License
Apr 25, 2017
Final Rule Places Six Synthetic Cannabinoids in Schedule I
Apr 24, 2017
Rosenberg Reports on Internal Reforms, Opioid Strategy, for Congress
Apr 14, 2017
New York Doctors Indicted in Prescription Drug, Fraud Schemes
Apr 10, 2017
Drug Ring Stole DEA Numbers to Obtain Oxycodone Pills; Leaders Sentenced
Mar 30, 2017
Fentanyl Analogue on Track for Schedule I
Mar 27, 2017
Recently Approved THC Drug Syndros to Schedule II

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.